Actelion is a biopharmaceutical company focused on innovative medicines for rare (orphan) diseases and pulmonary arterial hypertension.
Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. The company focused on drugs for rare (orphan) diseases and pulmonary arterial hypertension.
A pharmaceutical manufacturing and wholesale, program management, and software/technology organization providing U.S. Government customers the ability to procure a wide range of products.